Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature

Aberrant regulation of angiogenesis involves in the growth and metastasis of tumors, but angiogenesis inhibitors fail to improve overall survival of pancreatic cancer patients in previous phase III clinical trials. A comprehensive knowledge of the mechanism of angiogenesis inhibitors against pancrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Liu, Yang, Zhang, Zhen, Tan, Juan, Zhang, Junjun, Ou, Hao, Li, Jie, Song, Zewen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969999/
https://www.ncbi.nlm.nih.gov/pubmed/33748143
http://dx.doi.org/10.3389/fcell.2021.649265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969999/
https://www.ncbi.nlm.nih.gov/pubmed/33748143
http://dx.doi.org/10.3389/fcell.2021.649265

Ejemplares similares